SUN PHARMA Share Price, Forecast, News and Quotes - Equitymaster
X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUN PHARMA Share Price   (SUNP)

Here is the latest stock price and chart of Sun Pharma. For more details, see the Sun Pharma company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.

REFRESH
Live BSE Quotes Jan 16, 2017 (Close)
Price (Rs)643.60 Open (Rs) 653.00 High (Rs) 654.80 Low (Rs) 642.45
% Change-1.17 Volume 122,213 Value (Rs) 79,080,920 52-Week H/L 898.00 / 572.40
Live NSE Quotes Jan 16, 2017 (Close)
Price (Rs)643.50 Open (Rs) 651.00 High (Rs) 654.90 Low (Rs) 642.20
% Change-1.45 Volume 1,349,694 Value (Rs) 873,883,365 52-Week H/L 898.45 / 571.90
Valuation
EPS (Rs)* 30.74 P/E Ratio (x) 20.93 Market Cap (Rs m) 1,548,986.23 P/BV (x) 4.93
  *Trailing 12 months earnings, excluding extraordinary / exceptional items. BSE Sensex | CNX Nifty

Charts
SUN PHARMA Stock Price Chart (Rs) - 1 Year
Loading...
 
Peer Group:
Quote & Graph
     
 S&P BSE SENSEX 
PERIOD
Advanced Charts new


Today's Market

Flattish Start to the Week; Oil & Gas Stocks Underperform(Closing)

The Indian share markets finished the day on positive note amid buying interest supported by realty and consumer durable stocks. IT, oil & gas stocks however finished the day in red.

Related Views On News

Sun Pharma: USFDA Observations Post Good Quarterly Performance (Quarterly Results Update - Detailed)

Dec 12, 2016

Sun Pharma has announced its September quarter (2QFY17) results. The company has reported 13.2% YoY growth in sales and a growth of 117% in the net profits. Here is our analysis of the results.

Sun Pharma: US Segment Shows Signs of Improvement (Quarterly Results Update - Detailed)

Sep 12, 2016

Sun Pharma has announced its 1QFY17 results. The company has reported 22.7% YoY growth in sales and a growth of 266% in the net profits. Here is our analysis of the results.

Sun Pharma: Acquisition synergies start contributing (Quarterly Results Update - Detailed)

Apr 1, 2016

Sun Pharma has announced its 3QFY16 results. Net sales have grown by 2.3% YoY, while net profits surged by 258% YoY. Here is our analysis of the results.

Glenmark: High Costs hit the Bottom line (Quarterly Results Update - Detailed)

Nov 8, 2016

Glenmark has announced its 2QFY16 results. The company has reported 15.7% YoY growth in net sales and 3.5% YoY increase in net profits. Here is our analysis of the results.

Biocon: High Other Income And Licensing Income Drive Growth (Quarterly Results Update - Detailed)

Nov 7, 2016

Biocon has announced its 2QFY17. The company has reported 19.8% YoY growth in net sales and profits of Rs 1.5 bn for the quarter. Here is our analysis of the results.

More Views on News

Most Popular

Demonetisation was NOT about Black Money. Here's Proof...(The 5 Minute Wrapup)

Jan 5, 2017

A not-so-shocking report confirms our suspicion.

Try to Imagine Your Own Funeral...(Vivek Kaul's Diary)

Jan 7, 2017

In the end...does it matter where Toyota builds its next plant...when the stock market next crashes...whether you own a mansion?

From Notebandi to Goldbandi(Daily Profit Hunter)

Jan 6, 2017

Asad Dossani discusses Demonitisation 2.0: Goldbandi. A hypothetical, but possible, event that could shape the gold market in 2017.

An IRR comparison for Hidden Treasure, Small cap index and Sensex(Chart Of The Day)

Jan 7, 2017

2016, with all its surprises, has laid a strong foundation for small cap businesses.

Will You Accumulate Money or Accumulate Value?(Outside View)

Jan 11, 2017

In life one must continue to add value wherever possible and inculcating this attitude will create long term wealth.

More

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUN PHARMA - ADCOCK INGRAM COMPARISON

Compare Company With Charts

COMPARE SUN PHARMA WITH

MARKET STATS